Founded by Nav Vij and Pang Sze Yunn in Singapore, Neurowzyr is dedicated to measuring and understanding early brain decline and related therapies. On a mission to address the need for proactive brain health monitoring and support, they shared a vision of “healthy brains, happier lives for everyone”. No other company in the world focuses on testing for early brain decline. Neurowyzer’s unique cognitive testing technology allows doctors to act on brain health issues early, swiftly and accurately. Its cost-effective, accurate and scalable solution promotes a preventative, proactive approach to brain health. By detecting and preventing severe brain health-related conditions, it mitigates the high cost these impose on individuals and society alike.
The Neurowyzr case can be used for the following courses/themes:
Entrepreneurship and Venture Creation
• Opportunity identification: how Neurowyzr identified the gap in the cognitive health market and built a business around early detection of brain aging.
• Business model innovation: analyse company’s revenue streams, partnerships, and scalability.
• Funding strategy: how early-stage health-tech startups raise capital, balance R&D investments, and commercialize scientific advancements.
Strategy and Competitive Advantage
• Market entry & positioning: how Neurowyzr differentiates itself from traditional neurology and wellness solutions.
• Regulatory challenges: how operating in healthcare, particularly with digital diagnostics, impacts the company’s strategy.
• Ecosystem & partnerships: how partnerships with hospitals, insurance providers, and employers give the company a competitive edge.
Digital Transformation in Healthcare
• Data monetization: how Neurowyzr uses digital tools for cognitive assessment; how it can scale such technology responsibly.
• Ethical considerations and bias in digital health: ethical challenges of digital diagnostics such as data privacy and inclusivity.
Healthcare Management and Policy
• Preventive healthcare business models: how cognitive health solutions align with shifting trends towards prevention rather than treatment.
• Regulatory hurdles: the challenges of bringing digital health solutions to different global markets.
- Digital transformation
- healthcare
- aging population
- entrepreneurship
- global business
- southeast Asia
- SDG3 Good Health & Well-Being
- SDG9 Industry, Innovation and Infrastructure
- Q22026